Ara
Toplam kayıt 26, listelenen: 21-26
Comparing the biological properties and chemical profiling of chestnut bee pollen and bee bread collected from Anatolia
(Springer, 2023)
Bee bread (BB) and bee pollen (BP) are accepted as functional food and considered in medical properties due to its important bioactive components. These bee products show different biological properties, but researches on ...
An investigation into chestnut honeys from Artvin province in Turkiye: their physicochemical properties, phenolic profiles and antioxidant activities
(Wiley, 2023)
The aim of this study was to investigate the physicochemical properties, phenolic compounds, and antioxidant activities of eight chestnut honey samples collected from Artvin province in Turkiye. The honey samples' phenolic ...
A study on 4-acylamino-4,5-dihydro-1H-1,2,4-triazol-5-ones
(2007)
Five novel 3-alkyl-4-phenylacetylamino-4,5-dihydro-1H-1,2,4-triazol-5-ones (2) were synthesized by the reactions of 3-alkyl-4-amino-4,5-dihydro-1H-1,2,4- triazol-5-ones (1) with phenylacetyl chloride and characterized by ...
DNA binding, antioxidant and antimicrobial activities of homo- and heteronuclear copper(II) and nickel(II) complexes with new oxime-type ligands
(Elsevier, 2010)
Some homo- and heteronuclear Cu(II) and Ni(II) complexes of new oxime-type ligands were tested against several pathogenic microorganisms to assess their antimicrobial potentials. The antimicrobial activities of complexes ...
Royal jelly can diminish secondary neuronal damage after experimental spinal cord injury in rabbits
(Elsevier, 2012)
The aim of this experimental study was to investigate the neuroprotective effect of Royal jelly (RJ) on traumatic spinal cord injury (SCI). Twenty-one New Zealand male rabbits, weighing between 2.5 and 3.0. kg were divided ...
Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity
(Elsevier, 2024)
Existing drugs that are being used to treat type-2 diabetes mellitus are associated with several side effects; thus, exploring potential drug candidates is still an utter need these days. Hybrids of indenoquinoxaline and ...